SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-21-015154
Filing Date
2021-06-24
Accepted
2021-06-24 08:18:18
Documents
14
Period of Report
2021-06-24
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 43693
2 ex99-1.htm EX-99.1 36659
3 ex99-1_001.jpg GRAPHIC 98216
  Complete submission text file 0001493152-21-015154.txt   400654

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE crbp-20210624.xsd EX-101.SCH 3035
5 XBRL LABEL FILE crbp-20210624_lab.xml EX-101.LAB 34914
6 XBRL PRESENTATION FILE crbp-20210624_pre.xml EX-101.PRE 22795
7 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3644
Mailing Address 500 RIVER RIDGE DRIVE NORWOOD MA 02062
Business Address 500 RIVER RIDGE DRIVE NORWOOD MA 02062 617-963-0103
Corbus Pharmaceuticals Holdings, Inc. (Filer) CIK: 0001595097 (see all company filings)

IRS No.: 464348039 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37348 | Film No.: 211040717
SIC: 2834 Pharmaceutical Preparations